![]() ![]() In connection with the proposed Business Combination between Envigo and AHPAC, AHPAC filed with the Securities and Exchange Commission ( SEC) a preliminary proxy statement and will file with the SEC and mail a definitive proxy statement and other relevant documentation to AHPACs shareholders. ![]() The following is an Investor Presentation, dated January 2018, which will be used by AHPAC with respect to the Business Combination.Īdditional Information about the Business Combination ( AHPAC) and Envigo International Holdings, Inc., a Delaware corporation ( Envigo) resulting in AHPAC becoming the ultimate parent company to Envigo and Envigos direct and indirect subsidiaries, pursuant to the terms of that certain Transaction Agreement (the Transaction Agreement) dated as of August 21, 2017, as amended on November 22, 2017, December 22, 2017 and January 21, 2018, by and among AHPAC, Avista Healthcare Merger Sub, Inc., a Delaware corporation and direct wholly-owned subsidiary of AHPAC, Avista Healthcare NewCo, LLC, a Delaware limited liability company and direct wholly-owned subsidiary of AHPAC, Envigo and Jermyn Street Associates, LLC, solely in its capacity as Shareholder Representative (as defined in the Transaction Agreement). This filing relates to the proposed business combination (the Business Combination) of Avista Healthcare Public Acquisition Corp. Subject Company: Avista Healthcare Public Acquisition Corp. Pursuant to rule 425 under the Securities Act of 1933 ![]() ![]() Filed by Avista Healthcare Public Acquisition Corp. ![]()
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |